NCT01042561

Vitamin D Status and Dose Response in Infants

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 64 (actual)
• Sponsor: University of Nebraska · Academic / Other
• Sex: All
• Age: 5 Minutes – 3 Months
• Healthy volunteers: Accepted

Summary

This study will examine the relationship of serum 25(OH)D levels in infants 32 weeks and greater gestation who are fed infant formula to markers of inflammation and bone metabolism.

Detailed description

It is hypothesized that serum 25(OH)D levels in infants 32 weeks and greater gestation are not maintained at optimal levels of greater than 32 ng/Ml with currently available infant formulas, and that this will have an inverse relationship with markers of inflammation and bone metabolism.

Conditions

• Vitamin D
• Prematurity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Vitamin D3	400 IU of vitamin D3 daily. Pts will recieve 1 mL a day with a feeding for 28 days.
DIETARY_SUPPLEMENT	vitamin D3 placebo	Placebo designed by research pharmacist. Pts will recieve 1 mL a day with feedings for 28 days.

Timeline

• Start date: 2009-08-07
• Primary completion: 2010-08-01
• Completion: 2010-08-01
• First posted: 2010-01-05
• Last updated: 2023-09-01

Locations

1 site across 1 country: United States